SE330166B - - Google Patents
Info
- Publication number
- SE330166B SE330166B SE00288/67A SE28867A SE330166B SE 330166 B SE330166 B SE 330166B SE 00288/67 A SE00288/67 A SE 00288/67A SE 28867 A SE28867 A SE 28867A SE 330166 B SE330166 B SE 330166B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Transmission Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19497262A | 1962-05-15 | 1962-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE330166B true SE330166B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-11-09 |
Family
ID=22719572
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE5253/63A SE323668B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1963-05-13 | |
| SE5254/63A SE323669B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1963-05-13 | |
| SE00288/67A SE330166B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1967-01-09 | |
| SE00290/67A SE330165B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1967-01-09 | |
| SE00289/67A SE330164B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1967-01-09 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE5253/63A SE323668B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1963-05-13 | |
| SE5254/63A SE323669B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1963-05-13 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE00290/67A SE330165B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1967-01-09 | |
| SE00289/67A SE330164B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1962-05-15 | 1967-01-09 |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3723533A (en) * | 1968-02-27 | 1973-03-27 | American Cyanamid Co | Substituted naphthalenone and naphthalenedione compounds |
| DE2718872A1 (de) * | 1976-06-14 | 1977-12-22 | Jenapharm Veb | Verfahren zur herstellung von neuen gona-4,9(10)-dienen |
| FR2618783B1 (fr) * | 1987-07-30 | 1991-02-01 | Roussel Uclaf | Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant |
| WO2015057894A1 (en) * | 2013-10-15 | 2015-04-23 | Massachusetts Institute Of Technology | Methods for treating polycystic kidney disease and polycystic liver disease |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3069421A (en) * | 1961-04-12 | 1962-12-18 | Roussel Uclaf | Process for the preparation of delta5(10)-estrene-17beta-ol-3-one and intermediates |
-
1962
- 1962-05-15 US US194972A patent/US3502699A/en not_active Expired - Lifetime
-
1963
- 1963-05-09 DE DE19631468642 patent/DE1468642B1/de active Pending
- 1963-05-09 DE DE1618973A patent/DE1618973C3/de not_active Expired
- 1963-05-09 DE DE1793633A patent/DE1793633C3/de not_active Expired
- 1963-05-13 SE SE5253/63A patent/SE323668B/xx unknown
- 1963-05-13 CH CH597463A patent/CH494213A/de not_active IP Right Cessation
- 1963-05-13 BR BR149095/63A patent/BR6349095D0/pt unknown
- 1963-05-13 FI FI0988/63A patent/FI41741B/fi active
- 1963-05-13 NO NO148646A patent/NO124598B/no unknown
- 1963-05-13 SE SE5254/63A patent/SE323669B/xx unknown
- 1963-05-14 ES ES288359A patent/ES288359A1/es not_active Expired
- 1963-05-14 DK DK228063AA patent/DK114340B/da unknown
- 1963-05-14 ES ES288360A patent/ES288360A1/es not_active Expired
- 1963-05-14 DK DK228263AA patent/DK116056B/da unknown
- 1963-05-14 IT IT10052/63A patent/IT1061776B/it active
- 1963-05-14 NO NO148662A patent/NO124597B/no unknown
- 1963-05-14 AT AT00125/68A patent/AT283609B/de not_active IP Right Cessation
- 1963-05-14 AT AT390463A patent/AT272532B/de active
- 1963-05-15 JP JP38024255A patent/JPS4812737B1/ja active Pending
- 1963-08-11 FR FR944790A patent/FR3896M/fr not_active Expired
-
1967
- 1967-01-09 SE SE00288/67A patent/SE330166B/xx unknown
- 1967-01-09 SE SE00290/67A patent/SE330165B/xx unknown
- 1967-01-09 SE SE00289/67A patent/SE330164B/xx unknown